Scalper1 News
Biotech GW Pharmaceuticals (GWPH) had investors in a buoyant mood after an epilepsy meeting over the weekend, leading Piper Jaffray to increase its price target and shares to rise 9% to a new high near 105 in early trading in the stock market today. At the first biennial conference of the Dravet Syndrome Foundation, devoted to a particularly severe form of childhood epilepsy, attendees listened to presentations on the efficacy of marijuana-derived Scalper1 News
Scalper1 News